| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 19,473 | 18,447 | 20,060 | | Cost of Revenue | 5,783 | 5,784 | 5,675 | | | Gross Profit | 13,690 | 12,663 | 14,385 | | | Operating Expenses | | Research Development | 6,185 | 5,714 | 6,118 | | Selling General and Administrative | 6,116 | 5,396 | 5,763 | | Non Recurring | 3,683 |
-
|
-
| | Others |
-
| 295 |
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (2,294) | 1,258 | 2,504 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,540) | (13,105) | (222) | | Earnings Before Interest And Taxes | (5,834) | (11,847) | 2,282 | | Interest Expense | 64 |
-
|
-
| | Income Before Tax | (5,898) | (11,847) | 2,282 | | Income Tax Expense | 525 | 108 | 1,373 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (6,423) | (11,955) | 909 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (6,423) | (11,955) | 909 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($6,423) | ($11,955) | $909 |
|
0.02% Nasdaq 0.00%
Income Statement
